UPDATE: BofA Securities Upgrades Ascendis Pharma (ASND) to Buy After Positive Ph3 Data
Tweet Send to a Friend
(Updated - March 16, 2022 8:46 AM EDT)
BofA Securities analyst Tazeen Ahmad upgraded Ascendis Pharma (NASDAQ: ASND) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad upgraded Ascendis Pharma (NASDAQ: ASND) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
